Search results for: Karl Claxton
Filter search results
OHE Occasional Paper Critiques the Claxton et al. £13,000 per QALY Estimate
24 February 2015
OHE has published an Occasional Paper highlighting the significant shortage of data that forced Claxton et al. to rely on a large number of strong assumptions to produce their results….
Critique of Research Proposing to Lower NICE’s Cost-per-QALY Threshold to £12,936
2 December 2013
…recently-published recommendation by Claxton et al[2] that NICE should lower its cost-per-QALY threshold from the current £20,000–£30,000 official range to £12,936. The Claxton et al paper is an excellent attempt…
Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold
12 January 2013
This paper counters the recently-published recommendation by Claxton et al[1] that NICE should lower its cost-per-QALY threshold from the current £20,000–£30,000 official range to £12,936. The Claxton et al paper…
Cost-Effectiveness Thresholds and Expert Elicitation: a Bridge Too Far?
29 April 2021
…by Claxton et al. (2015) sought to find a threshold that reflected the marginal productivity of expenditure in the NHS in England. They estimated a threshold of £12,936 per QALY…
Are Discount Rates Used in UK Vaccine Economic Evaluations Jeopardising Investment in Immunisation Programmes?
4 August 2020
…(Attema, Brouwer and Claxton, 2018; Claxton et al., 2011)and its level is currently under review as part of the NICE methods review. In fact, one of the reasons the discount…
Spotlight on OHE: Opportunity Costs of NICE Decisions in Wales and HESG 2015
20 January 2015
…in healthcare spending)” written by Beth Woods, Paul Revill, Mark Sculpher and Karl Claxton of the University of York. By emphasising that thresholds should be based on forgone benefit rather…
OHE Presentations at HTAi: Tokyo 2016
24 May 2016
…the evidence in the UK on the opportunity cost of NICE decisions, looking at the Claxton et al. work, the Barnsley et al critique, and work by Karlsberg Schaffer et…
LSE-ICL Medical Innovation Forum on 14th October 2015: Assessing Value and Sustainable Financing of Innovative Therapies.
29 September 2015
…innovative medical technologies. Professor Alistair McGuire (LSE Health) will present on this topic, and this will be followed by a discussion with six experts, including Professor Karl Claxton (University of…